English | Español
Press release submission | Apr 28, 2018

PFIZER: MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy
Press release submission | Apr 28, 2018

TEXAS MEDICAL CENTER: A New Era for the Texas Medical Center
Press release submission | Apr 28, 2018

CLEVELAND CLINIC: New MS Guidelines Call for Treatment Sooner
Press release submission | Apr 28, 2018

MASSACHUSETTS GENERAL HOSPITAL: Imaging may allow safe tPA treatment of patients with unwitnessed strokes
Press release submission | Apr 28, 2018

PFIZER: Pfizer Provides Update on Proposed Trastuzumab Biosimilar
Press release submission | Apr 27, 2018

MASSACHUSETTS GENERAL HOSPITAL: Study identifies overdose risk factors in youth with substance use disorders
Press release submission | Apr 27, 2018

TEXAS MEDICAL CENTER: Regaining a Sense of Smell
Press release submission | Apr 27, 2018

CLEVELAND CLINIC:Research Links Proper Sleep to Better Dietary Choices

Trending
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments